ATE246704T1 - Verwendung von phytosterol und/oder phytostanolestern - Google Patents

Verwendung von phytosterol und/oder phytostanolestern

Info

Publication number
ATE246704T1
ATE246704T1 AT99122978T AT99122978T ATE246704T1 AT E246704 T1 ATE246704 T1 AT E246704T1 AT 99122978 T AT99122978 T AT 99122978T AT 99122978 T AT99122978 T AT 99122978T AT E246704 T1 ATE246704 T1 AT E246704T1
Authority
AT
Austria
Prior art keywords
phytosterol
phytostanol esters
phytostanol
esters
Prior art date
Application number
AT99122978T
Other languages
English (en)
Inventor
David Carl Burdick
Gerard Moine
Daniel Raederstorff
Peter Weber
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26149828&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE246704(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE246704T1 publication Critical patent/ATE246704T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B1/00—Production of fats or fatty oils from raw materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
    • A23D9/013—Other fatty acid esters, e.g. phosphatides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Wood Science & Technology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Edible Oils And Fats (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT99122978T 1998-11-26 1999-11-19 Verwendung von phytosterol und/oder phytostanolestern ATE246704T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98122412 1998-11-26
EP99119337 1999-09-29

Publications (1)

Publication Number Publication Date
ATE246704T1 true ATE246704T1 (de) 2003-08-15

Family

ID=26149828

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99122978T ATE246704T1 (de) 1998-11-26 1999-11-19 Verwendung von phytosterol und/oder phytostanolestern

Country Status (17)

Country Link
US (4) US20020160990A1 (de)
EP (1) EP1004594B1 (de)
JP (1) JP2000159792A (de)
KR (1) KR100678831B1 (de)
CN (2) CN1272011C (de)
AR (1) AR025141A1 (de)
AT (1) ATE246704T1 (de)
AU (1) AU762539B2 (de)
BR (1) BR9905398A (de)
CA (1) CA2290331C (de)
DE (1) DE69910152T2 (de)
DK (1) DK1004594T3 (de)
ES (1) ES2204052T3 (de)
ID (1) ID24148A (de)
MX (1) MX215122B (de)
NO (1) NO314357B1 (de)
NZ (1) NZ501169A (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1155104A2 (de) * 1999-02-10 2001-11-21 Eastman Chemical Company Maisfasern für die herstellung von wertvollen verbindungen und materialien
US6998501B1 (en) * 1999-08-30 2006-02-14 Ocean Nutrition Canada Limited Nutritional supplement for lowering serum triglyceride and cholesterol levels
WO2001015552A1 (en) * 1999-08-30 2001-03-08 Ocean Nutrition Canada Ltd. A nutritional supplement for lowering serum triglyceride and cholesterol levels
US6838098B2 (en) 2000-09-07 2005-01-04 Cadbury Adams Usa, Llc Continuous formation of center filled gum
SE523094C2 (sv) * 2001-01-11 2004-03-30 Karlshamns Ab Förfarande för framställning av en fettkomposition som innehåller sterolestrar, fria steroler och glycerider, fettkomposition framställd genom förfarandet samt fettkompositionens användning
US6623266B2 (en) 2001-01-19 2003-09-23 Cadbury Adams Usa Llc Apparatus for making a center-filled gum lollipop with hard candy shell
KR20020081834A (ko) * 2001-04-20 2002-10-30 주식회사 유엘바이오텍 식물성 스테롤의 유도체를 이용한 혈중 콜레스테롤저하제의 제조방법 및 이에 의해 제조된 혈중 콜레스테롤저하제
KR100440613B1 (ko) * 2001-04-20 2004-08-16 주식회사 유엘바이오텍 식물성스테롤과 생 플라보노이드의 결합체를 이용한 혈중콜레스테롤 저하제의 제조방법과 이에 의해 제조한 혈중콜레스테롤 저하제
EP1275309A1 (de) * 2001-07-13 2003-01-15 Ikeda Food Research Co. Ltd. Sterol Fettsäure Ester Zusammensetzung und diese enthaltende Lebensmittel
WO2003009854A1 (en) * 2001-07-20 2003-02-06 Lonza Ag Lipid lowering composition comprising carnitine and phytosterol
FI20012553A0 (fi) * 2001-12-21 2001-12-21 Raisio Benecol Oy Syötävät koostumukset
BR0309133A (pt) * 2002-04-10 2005-02-01 Cargill Inc Composições de esteril éster dispersáveis aquosas
US8821915B2 (en) 2002-08-09 2014-09-02 Veroscience, Llc Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders
US20040081678A1 (en) 2002-08-09 2004-04-29 Anthony Cincotta Therapeutic process for the treatment of obesity and associated metabolic disorders
WO2004091603A1 (fr) * 2003-04-07 2004-10-28 Clinigenetics Utilisation d’un ester de dha pour le traitement des malades cardiovasculaires
EP1466597A1 (de) * 2003-04-07 2004-10-13 Clinigenetics Verwendung von dha-Esteren in der Behandlung kardiovasculärer Krankheiten
KR101054913B1 (ko) * 2003-12-31 2011-08-05 주식회사 삼양제넥스 식물스테롤, 헤스페리딘 및 루틴을 포함하는 고지혈증,동맥경화증 및 간질환 예방 및 치료용 조성물
US8158184B2 (en) * 2004-03-08 2012-04-17 Bunge Oils, Inc. Structured lipid containing compositions and methods with health and nutrition promoting characteristics
US7641926B2 (en) 2004-08-25 2010-01-05 Cadbury Adams Usa, Llc Liquid-filled chewing gum composition
US7727565B2 (en) 2004-08-25 2010-06-01 Cadbury Adams Usa Llc Liquid-filled chewing gum composition
US7678399B2 (en) 2005-12-05 2010-03-16 Bunge Oils, Inc. Phytosterol containing deep-fried foods and methods with health promoting characteristics
JP2009532065A (ja) 2006-04-05 2009-09-10 キャドバリー アダムス ユーエスエー エルエルシー 酸含有チューインガム中のリン酸カルシウム錯体
EP2001436B1 (de) 2006-04-05 2017-01-04 Intercontinental Great Brands LLC Calciumphosphatkomplex und salze in oralen freisetzungssystemen
US20070298079A1 (en) * 2006-06-26 2007-12-27 Tropicana Products, Inc. Food fortified with omega-3 fatty acids
PL2076142T3 (pl) 2006-06-29 2020-05-18 Intercontinental Great Brands Llc Usprawniona przecinarka łańcuchowa do ciągłego formowania kawałków gumy do żucia z nadzieniem
GB0905367D0 (en) * 2009-03-27 2009-05-13 Danisco Method
US9352025B2 (en) 2009-06-05 2016-05-31 Veroscience Llc Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders
CN101919537B (zh) * 2010-09-09 2012-08-08 浙江大学 植物甾烷醇酯和共轭亚油酸酯在功能性肉制品中的应用
FI123374B (fi) * 2011-03-25 2013-03-15 Ravintoraisio Oy Uusi syötävä koostumus
CN102318686B (zh) * 2011-06-01 2012-12-19 黑龙江省大豆技术开发研究中心 一种制备含有植物甾醇酯的功能性保健油脂的方法
CN102603846A (zh) * 2012-02-03 2012-07-25 江南大学 一种离子液体中植物甾醇酯的制备方法
CN103242407A (zh) * 2013-05-15 2013-08-14 张雅茹 含多不饱和脂肪酰基的磷脂酰甾醇和/或磷脂酰甾烷醇及制备方法和应用
IL237290A0 (en) * 2015-02-17 2015-06-30 Enzymotec Ltd Oil mixtures for use in formulas
ES2988519T3 (es) * 2015-04-23 2024-11-20 Basf Se Cápsula de gel que contiene esterol y solubilizante
CN109200061A (zh) * 2017-06-29 2019-01-15 四川国为制药有限公司 一种高纯度鱼油与植物甾醇酯的降血脂组合物
WO2020259493A1 (en) * 2019-06-24 2020-12-30 Basf Se Compositions and methods for the prevention or treatment, or dietary management of nafld
CN113197310A (zh) * 2021-05-21 2021-08-03 江苏越红生物科技有限公司 一种富含油酸的植物甾醇酯的制备方法
CN120860036B (zh) * 2025-09-29 2026-01-27 湖南农业大学 一种植物甾醇和植物甾醇酯复合剂及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE30910E (en) * 1971-03-19 1982-04-20 Intellectual Property Development Corporation Reducing cholesterol levels
US4588717A (en) * 1984-06-13 1986-05-13 David C. Mitchell Medical Research Institute Compounds and vitamin supplements and methods for making same
AU664827B2 (en) * 1991-05-03 1995-12-07 Raisio Benecol Ltd. A substance for lowering high cholesterol level in serum and a method for preparing the same
US5593691A (en) * 1993-06-03 1997-01-14 Marigen S.A. Biotenside solvents for pharmaceuticals and cosmetics
FI107015B (fi) * 1996-08-09 2001-05-31 Raisio Benecol Oy Kasvistanolirasvahappoestereiden seos ja sen käyttö sekä elintarvike
AU4891699A (en) * 1998-07-20 2000-02-14 Forbes Medi-Tech Inc. Compositions comprising phytosterol, phytostanol or mixtures of both and omega-3fatty acids or derivatives thereof and use of the composition in treating or preventing cardiovascular disease and other disorders
US5892068A (en) * 1998-08-25 1999-04-06 Mcneil-Ppc, Inc. Preparation of sterol and stanol-esters

Also Published As

Publication number Publication date
BR9905398A (pt) 2000-08-08
CA2290331A1 (en) 2000-05-26
CN1272011C (zh) 2006-08-30
ES2204052T3 (es) 2004-04-16
AU762539B2 (en) 2003-06-26
US20050261259A1 (en) 2005-11-24
EP1004594B1 (de) 2003-08-06
KR20000035619A (ko) 2000-06-26
DE69910152D1 (de) 2003-09-11
US20020055493A1 (en) 2002-05-09
CN1135234C (zh) 2004-01-21
NZ501169A (en) 2001-05-25
MX9910678A (en) 2000-04-30
AU6065599A (en) 2000-06-01
NO314357B1 (no) 2003-03-10
NO995784L (no) 2000-05-29
DK1004594T3 (da) 2003-11-17
ID24148A (id) 2000-07-13
JP2000159792A (ja) 2000-06-13
CA2290331C (en) 2008-01-15
CN1494909A (zh) 2004-05-12
CN1256277A (zh) 2000-06-14
EP1004594A1 (de) 2000-05-31
US20020160990A1 (en) 2002-10-31
MX215122B (en) 2003-07-08
AR025141A1 (es) 2002-11-13
DE69910152T2 (de) 2004-06-09
US20070078115A1 (en) 2007-04-05
NO995784D0 (no) 1999-11-25
KR100678831B1 (ko) 2007-02-05

Similar Documents

Publication Publication Date Title
DE69910152D1 (de) Verwendung von Phytosterol und/oder Phytostanolestern
DE59903869D1 (de) Verwendung von nanoskaligen sterolen und sterolestern
DE69831755D1 (de) Optoakustische kontrastmittel und anwendungsverfahren
EP1047426A4 (de) Verwendung von methylnaltrexon und verwandten verbindungen
ATE329599T1 (de) Neue verwendung von budesonide und formoterol
DE69532671D1 (de) Endoprothesen und stents
DE69637691D1 (de) Azeotropähnliche zusammensetzungen und ihre verwendung
DE69638056D1 (de) Azeotropähnliche zusammensetzungen und ihre verwendung
DE69835020D1 (de) Plasmabrenner und verwendungsverfahren dieses plasmabrenners
ATE186447T1 (de) Zusammensetzung und verwendung
DE69834372D1 (de) Flüssigkristalline Polyester Zusammensetzungen und Verwendung
DE59710130D1 (de) Verwendung verbindungsverfahrens und verbindungsverfahren
DE69930647D1 (de) Struktur-analoga von amin-basen und nucleosiden
DE59905437D1 (de) Toner und/oder Toner-Mischungen
DE69529156D1 (de) Verwendung von amino-hydrierten chinazolinverbindungen und ihren derivaten zur entwöhnung bei drogenabhängigkeit
DE69812784D1 (de) Zusammensetzung zur Vorbeugung und Beseitigung von Pflanzenkrankheiten
DE69934889D1 (de) Herstellung und reinigung von diboranen
DE59710003D1 (de) Salze von 1-Hydroxy-dihydrophospholoxiden und 1-Hydroxy-phospholanoxiden und ihre Verwendung als Flammschutzmittel
DE59606486D1 (de) Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
DE69414028D1 (de) Lasersystem und Verwendung des Lasersystems
DE69808266D1 (de) Herstellung und verwendung von alpha-ketoamid derivate und anordnunge
DE69620914D1 (de) Perfluoralkoxycycloalkancarbonylfluorid-zusammensetzungen und ihre verwendung
DE69717677D1 (de) Koproduktion von perfluormethylperfluorvinylether und perfluorethylperfluorvinylether
DE69524590D1 (de) Zusammensetzung von 5htida und 5htid antagonisten
DE59307396D1 (de) Dichtring und verwendung desselben

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties